CECCARDI, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 28
EU - Europa 28
NA - Nord America 13
Totale 69
Nazione #
SG - Singapore 21
IT - Italia 17
US - Stati Uniti d'America 10
TR - Turchia 6
RU - Federazione Russa 5
CA - Canada 3
GB - Regno Unito 2
CN - Cina 1
DE - Germania 1
IE - Irlanda 1
LT - Lituania 1
NL - Olanda 1
Totale 69
Città #
Singapore 18
Istanbul 6
Cologno Monzese 4
Florence 4
Cascina 3
Catania 2
Ottawa 2
Dublin 1
Munich 1
Toronto 1
Totale 42
Nome #
Increased risk of functional neurological disorders following SARS‐CoV‐2 vaccination 21
Photophobia and migraine outcome during treatment with galcanezumab 11
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine 10
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor 9
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients 9
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine 8
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab 8
Totale 76
Categoria #
all - tutte 466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 466


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202410 0 0 0 0 0 0 0 0 0 0 9 1
2024/202566 4 0 0 33 16 13 0 0 0 0 0 0
Totale 76